1.
Fazio F, Lapietra G, Limongi MZ, Intoppa S, Milani ML, Piciocchi A, et al. MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis [Internet]. 2023 Aug. 29 [cited 2024 Apr. 16];15(1):e2023047. Available from: https://www.mjhid.org/mjhid/article/view/5381